Table: SymBio Pharmaceuticals -Q1 group results

SymBio Pharmaceuticals

07/05/2026 07:31

May 7 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Mar 31, 2026        Mar 31, 2025      Dec 31, 2026  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            233 mln             264 mln            3.89      
                 (-11.6 pct)         (-55.8 pct)      (+197.5 pct)  
  Operating       loss 2.34           loss 1.17         loss 4.23   
  Recurring       loss 2.39           loss 1.29         loss 4.29   
  Net             loss 2.40           loss 1.32         loss 4.33   
  EPS          loss 35.89 yen      loss 27.95 yen    loss 72.81 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T